Successfully listed in Hong Kong stock exchange together with China Isotope & Radiation Corporation as a whole. (Stock code: 01763.HK)
Being selected as one of the G20 enterprises in “Beijing Biomedical Industry Leap-Forward Development Project (G20 Project)”.
Being selected as one of the key enterprises in the “Ten-Hundred-Thousand” Project in Zhongguancun National Independent Innovation Demonstration Zone.
The controlling shareholder had been shifted from China Institute of Atomic Energy (CIAE) to China Isotope & Radiation Corporation (CIRC).
HTA was identified as a high-tech enterprise, and successfully passed the re-identification in October 2011, November 2014 and August 2017.
Successfully listed on the National Equities Exchange and Quotations, becoming the first listed company in the NEEQ among the nuclear technology application system in China National Nuclear Corporation (CNNC).
HTA completed capital increase and share expansion.